Logo image of ALGS

ALIGOS THERAPEUTICS INC (ALGS) Stock Analyst Ratings

NASDAQ:ALGS - Nasdaq - US01626L2043 - Common Stock - Currency: USD

18.63  -2.22 (-10.65%)

After market: 19.5 +0.87 (+4.67%)

Buy % Consensus

84

ChartMill assigns a Buy % Consensus number of 84% to ALGS. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 68.85. This target is 269.57% above the current price.
ALGS was analyzed by 9 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about ALGS.
In the previous month the buy percentage consensus was at a similar level.
ALGS was analyzed by 9 analysts. More opinions would make the average more meaningful.

Related screens

ALGS Historical Analyst RatingsALGS Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -51 -46 -41 -36 -31 -26 -21 -16 -11 -6 -1 2 4 6 8 10

Price Target & Forecast

Price Low Median Mean High 18.6360.6068.8568.8578.75 - 225.28% 269.57% 269.57% 322.71%

Related screens

ALGS Current Analyst RatingALGS Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4
Up and Down Grades
Date Firm Action Rating
2024-11-07 HC Wainwright & Co. Reiterate Buy -> Buy
2024-10-23 HC Wainwright & Co. Reiterate Buy -> Buy
2024-09-20 HC Wainwright & Co. Reiterate Buy -> Buy
2024-08-19 HC Wainwright & Co. Initiate Buy
2023-01-17 Piper Sandler Maintains Overweight
2023-01-06 Piper Sandler Upgrade Neutral -> Overweight
2023-01-06 Jefferies Upgrade Hold -> Buy
2022-11-03 SVB Leerink Maintains Market Perform
2022-05-05 SVB Leerink Downgrade Outperform -> Market Perform
2022-03-11 SVB Leerink Maintains Outperform
2022-03-11 Piper Sandler Maintains Overweight
2022-02-16 SVB Leerink Maintains Outperform
2022-01-07 SVB Leerink Maintains Outperform
2022-01-07 JP Morgan Downgrade Overweight -> Neutral
2021-09-09 SVB Leerink Initiate Outperform